Tapewire

Nasdaq · USD

VVOS

Vivos Therapeutics, Inc.

Export transactions ↓
Tapewire entity
8396
SEC CIK
0001716166
Parsed reports
55

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 25, 2021 Filed May 26, 2021 01:45 UTC
Huntsman Ronald KirkDirector · Chief Executive Officer
PurchaseCommon Stock 4,000 $5.38 $21,520.00
Disclosure

SEC source: 0001493152-21-012901 · ownership.xml · nonDerivative · entry 1

Huntsman Ronald Kirk · CIK 0001835498 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,500

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.335 to $5.40.

Read SEC document
March 12, 2021 Filed Mar 18, 2021 00:48 UTC
Amman Bradford K.Chief Financial Officer
GrantStock Option · Derivative 100,000 $7.50 Strike: $7.50 $750,000.00
Disclosure

SEC source: 0001493152-21-006291 · ownership.xml · derivative · entry 2

Amman Bradford K. · CIK 0001425339 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,001

Underlying: Common Stock · 100,000 shares

Expires 2026-03-12

F1 · derivative.exercise_date: 100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.

Read SEC document
March 12, 2021 Filed Sep 3, 2021 01:27 UTC
Amman Bradford K.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 100,000 $7.50 Strike: $7.50 $750,000.00
Disclosure

SEC source: 0001493152-21-021915 · ownership.xml · derivative · entry 3

Amman Bradford K. · CIK 0001425339 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-03-12

F2 · derivative.exercise_date: 100,000 stock options granted on March 12, 2021. One-fifth vested immediately and one-fifth vests annually on each anniversary date through March 12, 2025.

Read SEC document
December 24, 2020 Filed Dec 28, 2020 11:21 UTC
Amman Bradford K.Chief Financial Officer
PurchaseCommon Stock 1,000 $7.38 $7,380.00
Disclosure

SEC source: 0001493152-20-024301 · ownership.xml · nonDerivative · entry 1

Amman Bradford K. · CIK 0001425339 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document
December 23, 2020 Filed Dec 23, 2020 23:53 UTC
Huntsman Ronald KirkDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 1,000 $7.27 $7,266.90
Disclosure

SEC source: 0001493152-20-024277 · ownership.xml · nonDerivative · entry 1

Huntsman Ronald Kirk · CIK 0001835498 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

F1 · ownership.direct: 1,000 shares purchased in prices ranging from $7.25 through $7.2798 per share.

Read SEC document
December 11, 2020 Filed Dec 14, 2020 13:45 UTC
Huntsman Ronald KirkDirector · Chief Executive Officer · 10% owner
PurchaseCommon Stock 500 $8.50 $4,250.00
Disclosure

SEC source: 0001493152-20-023466 · ownership.xml · nonDerivative · entry 1

Huntsman Ronald Kirk · CIK 0001835498 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Read SEC document
November 18, 2019 Filed Sep 3, 2021 01:27 UTC
Amman Bradford K.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 16,667 $7.50 Strike: $7.50 $125,002.50
Disclosure

SEC source: 0001493152-21-021915 · ownership.xml · derivative · entry 4

Amman Bradford K. · CIK 0001425339 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,667

Underlying: Common Stock · 16,667 shares

Expires 2024-11-18

F3 · derivative.exercise_date: 16,667 stock options granted on November 18, 2019. One-fifth vested immediately and one-fifth vests annually on each anniversary date through November 18, 2023.

Read SEC document
October 22, 2018 Filed Sep 3, 2021 01:27 UTC
Amman Bradford K.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 83,334 $7.50 Strike: $7.50 $625,005.00
Disclosure

SEC source: 0001493152-21-021915 · ownership.xml · derivative · entry 5

Amman Bradford K. · CIK 0001425339 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,334

Underlying: Common Stock · 83,334 shares

Expires 2023-10-22

F4 · derivative.exercise_date: 83,334 stock options granted on October 22, 2018. One-fifth vested immediately and one-fifth vests annually on each anniversary date through October 22, 2022

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.